Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review

被引:64
作者
Milloy, Michael-John S. [2 ]
Marshall, Brandon D. L. [3 ]
Kerr, Thomas [4 ]
Buxton, Jane [2 ,5 ]
Rhodes, Tim [6 ]
Montaner, Julio [4 ]
Wood, Evan [1 ,4 ]
机构
[1] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Urban Hlth Res Initiat, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada
[3] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA
[4] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[5] British Columbia Ctr Dis Control, Vancouver, BC, Canada
[6] London Sch Hyg & Trop Med, London WC1, England
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
antiretroviral therapy; CD4; cells; drug users; pathogenesis; progression; risk factors; viral load; ACTIVE ANTIRETROVIRAL THERAPY; PRE-AIDS MORTALITY; CD4(+) CELL COUNT; C VIRUS-INFECTION; VIRAL LOAD; VIROLOGICAL RESPONSE; TREATMENT OUTCOMES; CRACK-COCAINE; ALCOHOL-USE; ADHERENCE;
D O I
10.1097/QAD.0b013e32835221cc
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To systematically review factors associated with HIV disease progression among illicit drug users, focusing on exposures exogenous to individuals that likely shape access and adherence to HIV treatment. Design: A systematic review of peer-reviewed English-language studies among HIV-seropositive illicit drug users with at least one of these endpoint of interest: a diagnosis of AIDS; death; changes/differences in CD4 cell counts; or changes/differences in plasma HIV-1 RNA levels. Methods: Articles were included if they reported factors associated with an outcome of interest among a group of illicit drug users. Studies were identified, screened and selected using systematic methods. Results: Of 2668 studies matching the search criteria, 58 (2%) met the inclusion criteria, all but one from North America or western Europe. Overall, 41 (71%) studies contained significant individual-level clinical characteristics or behaviors (e. g. illicit drug use) associated with disease progression. Fifteen studies (26%) identified significant social, physical, economic or policy-level exposures, including incarceration, housing status or lack of legal income. Conclusion: Although past studies demonstrate important environmental exposures that appear to shape access to care and subsequent disease progression, the limited literature to examine these factors demonstrates the need for future research to consider risk environment characteristics and the role they may play in shaping health outcomes from HIV infection among drug users through determining access and adherence to evidence-based care. (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:1049 / 1063
页数:15
相关论文
共 93 条
[1]   Soluble tumor necrosis factor α receptors (sTNF-Rs) in HIV-1-infected intravenous drug users:: Change in circulating sTNF-R type II level and survival for AIDS patients [J].
Ajello, F ;
La Licata, R ;
Lodato, M ;
Vitale, F ;
Bonura, F ;
Valenti, R ;
Bruno, M ;
Romano, N .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2000, 16 (03) :209-216
[2]  
Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008
[3]  
ALTICE FL, 2007, CLIN INFECT DIS, V45, P770, DOI DOI 10.1086/521166
[4]   Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs [J].
Altice, Frederick L. ;
Kamarulzaman, Adeeba ;
Soriano, Vincent V. ;
Schechter, Mauro ;
Friedland, Gerald H. .
LANCET, 2010, 376 (9738) :367-387
[5]   Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users [J].
Arnsten, JH ;
Demas, PA ;
Grant, RW ;
Gourevitch, MN ;
Farzodegan, H ;
Howard, AA ;
Schoenboum, EE .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2002, 17 (05) :377-381
[6]   Directly observed therapy to treat HIV infection in prisoners [J].
Babudieri, S ;
Aceti, A ;
D'Offizi, GP ;
Carbonara, S ;
Starnini, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (02) :179-180
[7]   Accessing Antiretroviral Therapy Following Release From Prison [J].
Baillargeon, Jacques ;
Giordano, Thomas P. ;
Rich, Josiah D. ;
Wu, Z. Helen ;
Wells, Katherine ;
Pollock, Brad H. ;
Paar, David P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (08) :848-857
[8]   Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users [J].
Barber, Y ;
Rubio, C ;
Fernández, E ;
Rubio, M ;
Fibla, J .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10) :1279-1288
[9]   Crack-Cocaine Use Accelerates HIV Disease Progression in a Cohort of HIV-Positive Drug Users [J].
Baum, Marianna K. ;
Rafie, Carlin ;
Lai, Shenghan ;
Sales, Sabrina ;
Page, Bryan ;
Campa, Adriana .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (01) :93-99
[10]   High risk of HIV-related mortality is associated with selenium deficiency [J].
Baum, MK ;
ShorPosner, G ;
Lai, SH ;
Zhang, GY ;
Fletcher, MA ;
Sauberlich, H ;
Page, JB .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 15 (05) :370-374